Abstract
Outlook for RNAi 2007' is a new report which provides a detailed insight into
the most effective use of this novel technology in the drug discovery and
development process. It puts into context where RNAi technology is being used
as a tool of choice within academia and the pharma industry for functional
genomic studies, drug target discovery and mechanism of action studies. The
development status RNAi based therapeutics is covered in detail, highlighting
the key companies in the field, outlining their pipelines and describing the
results of completed clinical trials.
| 
View Cart
